Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical TrialStefano Rusconi, Giulia Marchetti, Manuela Colafigli et al.|PLoS ONE|2013Cited by 42
Virological Success of Lopinavir/Ritonavir Salvage Regimen is Affected by an Increasing Number of Lopinavir/Ritonavir-Related MutationsMarco Bongiovanni, Antonella d’Arminio Monforte, Teresa Bini et al.|Antiviral Therapy|2003Cited by 25
Predictive Factors of Hyperlipidemia in HIV-Infected Subjects Receiving Lopinavir/RitonavirMarco Bongiovanni, Antonella d’Arminio Monforte, Teresa Bini et al.|AIDS Research and Human Retroviruses|2006Cited by 17
<scp>PROtein</scp> enriched <scp>MEDiterranean</scp> diet to combat undernutrition and promote healthy <scp>neuroCOGnitive</scp> ageing in older adults: The <scp>PROMED‐COG</scp> consortium projectRoisin F O'Neill, Claire T. McEvoy, Fulvio Adorni et al.|Nutrition Bulletin|2022Cited by 14
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAARTStefano Rusconi, GC Marchetti, P Vitiello et al.|Journal of the International AIDS Society|2010Cited by 10